Literature DB >> 832904

Adjuvant activity of synthetic N-acetylmuramyl peptides in rats.

A Tanaka, R Saito, K Sugiyama, I Morisaki, S Kotani.   

Abstract

The minimal adjuvant-active structure in bacterial cell wall peptidoglycan for the induction of delayed hypersensitivity in rats (WKA) was the N-acetylmuramyl dipeptides (N-acetylmuramyl L-alanyl-D-isoglutamine and N-acetylmuramyl L-alanyl-D-glutamic acid).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832904      PMCID: PMC421367          DOI: 10.1128/iai.15.1.332-334.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

2.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

3.  Adjuvant effect of cord factor, a mycobacterial lipid.

Authors:  R Saito; A Tanaka; K Sugiyama; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans.

Authors:  J Fleck; M Mock; F Tytgat; C Nauciel; R Minck
Journal:  Nature       Date:  1974-08-09       Impact factor: 49.962

5.  Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.

Authors:  S Kotani; Y Watanabe; F Kinoshita; T Shimono; I Morisaki
Journal:  Biken J       Date:  1975-06
  5 in total
  11 in total

1.  Failure of synthetic muramyl dipeptide to increase antibacterial resistance.

Authors:  H Finger; C H Wirsing von König
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

Review 2.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

3.  Adjuvant activity of 6-amino-6-deoxy-muramyldipeptides and their acylamino derivatives on the induction of delayed hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; H Okumura; I Saiki; Y Tanio; M Kiso; A Hasegawa; Y Yamamura
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

4.  Adjuvant activities in production of reaginic antibody by bacterial cell wall peptidoglycan or synthetic N-acetylmuramyl dipeptides in mice.

Authors:  H Ohkuni; Y Norose; M Ohta; M Hayama; Y Kimura; M Tsujimoto; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

5.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

6.  Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.

Authors:  V Souvannavong; A Adam; E Lederer
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

7.  Stimulation of activated rat T cells in vitro by Listeria monocytogenes antigens.

Authors:  M C Woan; U K Forsum; D D McGregor
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

8.  Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.

Authors:  I Azuma; K I Kamisango; I Saiki; Y Tanio; S Kobayashi; Y Yamamura
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

9.  Macrophage activation by bacterial cell walls and related synthetic compounds.

Authors:  H Takada; M Tsujimoto; K Kato; S Kotani; S Kusumoto; M Inage; T Shiba; I Yano; S Kawata; K Yokogawa
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

10.  Muramyl dipeptide-induced adjuvant arthritis.

Authors:  S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.